COHANCE.NS Balance Sheet
Cohance Lifesciences Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:43
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹5.84 Bn | ₹5.67 Bn | ₹9.95 Bn | ₹19.90 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹1.65 Bn | ₹1.79 Bn | ₹2.55 Bn | ₹1.73 Bn | CapitalWorkInProgress |
| Goodwill | ₹0.00 Bn | ₹0.00 Bn | ₹6.55 Bn | ₹12.84 Bn | Goodwill |
| Other Intangible Assets | ₹0.79 Bn | ₹1.02 Bn | ₹0.63 Bn | ₹0.95 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹1.17 Bn | ₹1.31 Bn | ₹1.45 Bn | ₹2.62 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹0.03 Bn | ₹0.02 Bn | ₹0.05 Bn | ₹0.57 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹9.55 Bn | ₹9.91 Bn | ₹21.43 Bn | ₹39.02 Bn | NoncurrentAssets |
| Inventories | ₹3.13 Bn | ₹2.31 Bn | ₹1.67 Bn | ₹5.62 Bn | Inventories |
| Trade Receivables | ₹1.11 Bn | ₹1.34 Bn | ₹2.84 Bn | ₹6.81 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹0.65 Bn | ₹0.47 Bn | ₹0.85 Bn | ₹0.49 Bn | CashAndCashEquivalents |
| Current Investments | ₹4.19 Bn | ₹7.74 Bn | ₹1.92 Bn | ₹2.66 Bn | CurrentInvestments |
| Other Current Assets | ₹1.00 Bn | ₹0.63 Bn | ₹1.11 Bn | ₹2.17 Bn | OtherCurrentAssets |
| Total Current Assets | ₹10.11 Bn | ₹12.63 Bn | ₹8.53 Bn | ₹17.96 Bn | CurrentAssets |
| Total Assets | ₹19.66 Bn | ₹22.54 Bn | ₹30.32 Bn | ₹57.30 Bn | Assets |
| Equity Share Capital | ₹0.25 Bn | ₹0.25 Bn | ₹0.25 Bn | ₹0.38 Bn | EquityShareCapital |
| Other Equity | ₹17.10 Bn | ₹20.25 Bn | ₹16.71 Bn | ₹38.73 Bn | OtherEquity |
| Equity Attributable to Owners | ₹17.35 Bn | ₹20.51 Bn | ₹16.97 Bn | ₹39.11 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | ₹1.44 Bn | ₹1.23 Bn | NonControllingInterest |
| Total Equity | ₹17.35 Bn | ₹20.51 Bn | ₹18.41 Bn | ₹40.34 Bn | Equity |
| Long-term Borrowings | ₹0.05 Bn | ₹0.00 Bn | ₹0.06 Bn | ₹0.50 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹0.72 Bn | ₹0.97 Bn | ₹8.26 Bn | ₹10.50 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹0.65 Bn | ₹0.39 Bn | ₹0.72 Bn | ₹1.19 Bn | BorrowingsCurrent |
| Trade Payables | ₹0.65 Bn | ₹0.42 Bn | ₹0.80 Bn | ₹2.85 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹0.03 Bn | ₹0.07 Bn | ₹0.07 Bn | ₹0.59 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹1.59 Bn | ₹1.07 Bn | ₹3.65 Bn | ₹6.46 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹19.66 Bn | ₹22.54 Bn | ₹30.32 Bn | ₹57.30 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from COHANCE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).